|
|
||||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PAPER |
1 Psychiatric Clinic, Stavanger University Hospital, Stavanger, Norway
2 Department of Neurology, Faculty of Medicine, Istanbul University, Istanbul, Turkey
3 Department of Neurology, General Hospital Middelheim, Antwerpen, Belgium
4 Cognitive Drug Research Ltd, Oxon, UK
5 Novartis Pharmaceuticals, East Hanover, New Jersey, USA
Correspondence to:
Correspondence to:
K Brønnick
Psychiatric Clinic, Stavanger University Hospital, Helse Stavanger, Post Box 8100, 4068 Stavanger, Norway;bronnick{at}gmail.com
Objective: To investigate the effects of attentional deficits on activities of daily living (ADL) in patients with dementia associated with Parkinsons disease (PDD).
Method: 461 patients were assessed neuropsychologically. Factor analyses were used to differentiate attention from other cognitive functions and to differentiate different aspects of ADL functions. The effects of the attentional measure on ADL were examined using sequential multiple regression, controlling for age, sex, education, severity of motor symptoms and other cognitive functions.
Results: Three cognitive factors were identified, with one factor emerging as a measure of vigilance and focused attention. This factor predicted different aspects of ADL status even after controlling for motor functions and other cognitive factors. The attention factor was the single strongest cognitive predictor of ADL status, matching the strength of the effects of motor functions on ADL status.
Conclusion: Impaired attention is an important determinant of ADL functions in patients with PDD.
Abbreviations: ADAS-cog, Alzheimers Disease Assessment Scalecognitive; ADCS-ADL, Alzheimers Disease Cooperative StudyActivities of Daily Living; ADL, activities of daily living; CDR, Cognitive Drug Research; DLB, dementia with Lewy bodies; MMSE, Mini-Mental State Examination; PCA, principal component analysis; PDD, dementia associated with Parkinsons disease; UPDRS, Unified Parkinsons Disease Rating Scale
This article has been cited by other articles:
![]() |
D. Muslimovic, B. Post, J. D. Speelman, B. Schmand, R. J. de Haan, and For the CARPA Study Group Determinants of disability and quality of life in mild to moderate Parkinson disease Neurology, June 3, 2008; 70(23): 2241 - 2247. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |